Health · 4 views
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
Source Published 1h 14m ago Brief
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 4 Community interest
Brief read
AI Summary
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- AI-interpreted echocardiograms comparable to human reports, cardiologists' time cut by about 50%Continue reading
- Slow hands, quiet nights? Tai chi and a matched exercise class nudged sleep about equally in older men after cancerContinue reading
- After brain surgery, man sees cat's eyes in human facesContinue reading
- High lung pressure may protect newborns with diaphragmatic hernia from blood congestionContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow